The Addiction Crisis in Chateauguay

No city-level overdose data specific to Chateauguay, Quebec is publicly available. Chateauguay is located in the Montérégie health region. The most relevant sub-provincial data shows Montérégie recorded 45 suspected opioid-related deaths in 2021 (down from 75 in 2020), with non-fatal overdose emergency visits also tracked regionally. Addiction services for Chateauguay residents are provided through the Montérégie integrated health network (CISSS de la Montérégie-Ouest), with a centralized intake line at 450-443-4413 or toll-free 1-866-964-4413.

Nationally, Canada recorded approximately 7,560 apparent opioid toxicity deaths in 2023 and 7,150 in 2024 — a 17–23% decline driven largely by improvements in British Columbia, Alberta, and Ontario. Quebec is a stark exception: while the rest of Canada trends downward, Quebec's death toll rose to a record 645 in 2024 and is projected to remain near that level in 2025. Fentanyl contamination of the supply and lagging harm reduction investment are cited as primary causes of Quebec's divergence from the national trend.

01. What is happening in Chateauguay

Note: City-specific data for Chateauguay is limited. Figures reflect Quebec-wide trends.

02. A crisis that did not start this month

Quebec is experiencing a worsening opioid crisis that runs counter to national trends. In 2024, the province recorded 645 confirmed or suspected fatal overdoses — the highest total ever recorded — while opioid deaths dropped 17–23% nationally. Fentanyl or its analogues were detected in nearly two-thirds of opioid deaths by late 2024, up from 33% in 2017. In early 2025, health authorities detected two newly arrived ultra-potent nitazene compounds in Quebec drug supplies. Quebec's annual opioid death rate has risen from 5.1 per 100,000 (2018) to 7.3 per 100,000 (2024). Naloxone is available free of charge at all Quebec pharmacies for people aged 14 and over.

03. Why is it getting worse?

Quebec's worsening overdose crisis is driven by several converging factors: (1) the rapid spread of fentanyl and its analogues into the province's drug supply, now present in ~65% of opioid deaths; (2) the recent arrival of ultra-potent nitazene compounds (protodesnitazene and N-pyrrolidino-metonitazene) detected in Quebec samples in early 2025; (3) longstanding gaps in harm reduction infrastructure compared to western provinces; (4) COVID-19 pandemic disruptions to social supports and treatment access; and (5) stigma and cultural barriers that slow treatment-seeking. The Montérégie region, including Chateauguay, faces additional rural access challenges for addiction treatment and harm reduction services.

04. Where hope still lives

Communities across Quebec are responding with naloxone distribution, harm reduction programs, and peer support networks.

05. In the news

• Drug overdose deaths in Canada are dropping. So why is Quebec nearing a record high?CBC News · 2024
• Quebec on pace to record back-to-back years with 600 drug overdose deathsCBC News · 2025
• How to fight Quebec's toxic drug problem? A former user says change the conversationCBC News · 2025
• Opioid deaths dropped 23% in 2025 — bringing 'cautious optimism' from Canada's top doctorCBC News · 2025
• Quebec City public health warns of dangerous synthetic opioid 25 times stronger than fentanylCBC News · 2024
• Quebec continues to wrestle with opioid crisisCBC News · 2023